EcoDrugPlus

Glutamate Receptor, Ionotropic, Kainate 1a

Ensembl ID : ENSDARG00000069139
Gene Symbol: GRIK1A
7 Enzyme and pathways 5 Cross references
246 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 1b

Ensembl ID : ENSDARG00000040627
Gene Symbol: GRIK1B
8 Enzyme and pathways 5 Cross references
248 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 4

Ensembl ID : ENSDARG00000026753
Gene Symbol: GRIK4
6 Enzyme and pathways 5 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSDARG00000101449
Gene Symbol: GRIK5
5 Cross references
288 Possible Orthologues:

Glutamate Receptor, Metabotropic 2a

Ensembl ID : ENSDARG00000004150
Gene Symbol: GRM2A
6 Enzyme and pathways 5 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSDARG00000007195
Gene Symbol: GRM2B
5 Cross references
210 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSDARG00000031712
Gene Symbol: GRM3
5 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 4

Ensembl ID : ENSDARG00000040156
Gene Symbol: GRM4
6 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSDARG00000004445
Gene Symbol: GRM5A
9 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSDARG00000102067
Gene Symbol: GRM5B
5 Cross references
222 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSDARG00000062812
Gene Symbol: GLSA
12 Enzyme and pathways 5 Cross references
231 Possible Orthologues:

Glutaminase B

Ensembl ID : ENSDARG00000040705
Gene Symbol: GLSB
12 Enzyme and pathways 5 Cross references
174 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).